Amoy Diagnostics Co., Ltd. (300685-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Amoy Diagnostics Co., Ltd. maintains a healthy position.
This represents a growth rate of -100.000% compared to the previous year.
The year-on-year growth rate for receivables is -100.000%.
This represents a healthy year-on-year growth of -100.000%
This reflects a growth rate of -100.000% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
0.00
494.69
402.88
361.56
498.39
198.24
Receavebles
0.00
478.84
437.64
320.06
249.06
190.69
Inventory
0.00
32.84
32.27
21.43
17.16
14.07
Other
0.00
19.48
7.38
0.85
2.73
161.86
Total Current Assets
0.00
1285.14
1196.02
1008.76
797.41
564.95
Acc Payable
0.00
21.33
24.02
14.04
16.46
13.02
Short Term Debt
0.00
5.34
3.06
69.00
5.00
11.70
Other Current Liab
0.00
0.61
0.07
57.21
4.44
2.97
Current Liabilities
0.00
91.97
135.21
149.73
140.57
56.62
Capital Structure
When examining the capital structure of Amoy Diagnostics Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Amoy Diagnostics Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
